F8 and hemophilia A: As siblings with the same F8 pathogenic variant can have discrepant inhibitor responses and the risk of forming inhibitors is weakly associated with HLA variants (28, 29, 34), we hypothesized that genetic factors other than HLA and F8 affect the underlying immune response to FVIII, and thereby contribute to the distinct inhibitor signatures observed in patients with hemophilia A.